Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GAD65 gene-manipulated plants prevent diabetes in mice

April 21, 2004

New cathepsin K inhibitors in early development at Novartis

April 21, 2004

Anastrozole reported effective in preventing testosterone-induced gynecomastia

April 20, 2004

Metoprolol increases compliance and improves tolerability of sibutramine in obese patients

April 20, 2004

Clinical trials confirm the benefits of cinacalcet in secondary HPT

April 16, 2004

Subcutaneous icatibant produces positive results in bioavailability study

April 16, 2004

Three series of DPP-IV inhibitors prepared and tested at Boehringer Ingelheim

April 16, 2004

CS-917 completes second phase IIa trial

April 15, 2004

Sangart cleared to commence Swedish phase II trial of Hemospan

April 15, 2004

Dual PPARalpha/gamma agonists under investigation for metabolic syndromes at Dr. Reddy

April 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.